Carcinoma, Hepatocellular: all 3,251 studies
Page 18 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular CarcinomaCompletedNCT05117047
- Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib TreatmentStatus unknownNCT05113290Phase 4
- Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous AblativeActive, not recruitingNCT05113186Phase 2
- Holmium-166 Retrospective Collection of Real-World DataCompletedNCT05111795
- Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular CarcinomaWithdrawnNCT05111314Early Phase 1
- Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular CarcinomaWithdrawnNCT05109052Phase 1/2
- Predictive Power of Share Wave Fibro Scan in HCC After HCV InfectionCompletedNCT05105828
- Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular CarcinomaStatus unknownNCT05105815Early Phase 1
- Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver TransplantTerminatedNCT05103904Phase 2
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid TumorsActive, not recruitingNCT05103631Phase 1
- Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based TherapyCompletedNCT05101629Phase 2
- A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular CarcinomaCompletedNCT05099848Phase 2
- Hepatocellular Carcinoma Imaging Using PSMA PET/CTCompletedNCT05095519Phase 2
- Role of DEB-TACE Versus c-TACE in Treatment of HCCStatus unknownNCT05093920Early Phase 1
- SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular CarcinomaTerminatedNCT05093608Phase 1
- The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular CarcinomaStatus unknownNCT05088811
- Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)Status unknownNCT05088733Early Phase 1
- Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular CarcinomaStatus unknownNCT05087459
- Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOActive, not recruitingNCT05078047Phase 3
- Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsActive, not recruitingNCT05075993Phase 1
- B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular CarcinomaActive, not recruitingNCT05070156Early Phase 1
- A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy VolunteersCompletedNCT05068193Phase 1
- Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCCCompletedNCT05068076Not applicable
- ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskActive, not recruitingNCT05064553
- TheraSphere With Durvalumab and Tremelimumab for HCCActive, not recruitingNCT05063565Phase 2
- Personalized Cancer Vaccine in Egyptian Cancer PatientsStatus unknownNCT05059821Phase 1
- Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCCCompletedNCT05059665
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCCStatus unknownNCT05056337Phase 3
- Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular CarcinomaStatus unknownNCT05053386Not applicable
- The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in EgyptCompletedNCT05047146
- Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRTCompletedNCT05045573
- Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular CarcinomaTerminatedNCT05044676
- The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCCStatus unknownNCT05042336Phase 1/2
- Natural Killer (NK) Cell Therapy in Locally Advanced HCCCompletedNCT05040438Phase 2
- Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular CarcinomaCompletedNCT05040347
- A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line TherapyWithdrawnNCT05039736Phase 2
- A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory TrialCompletedNCT05038397Not applicable
- Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
- Immunotherapy for Advanced Liver CancerSuspendedNCT05033522Phase 2/3
- HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCCStatus unknownNCT05029973Phase 2
- Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular CarcinomaStatus unknownNCT05024539
- A Phase I Study of ERY974 in Patients With Hepatocellular CarcinomaActive, not recruitingNCT05022927Phase 1
- SBRT With DIBH for HCC After TACE and Lipiodol MarkingActive, not recruitingNCT05021250Not applicable
- Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular CarcinomaCompletedNCT05017922Not applicable
- Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular CarcinomaActive, not recruitingNCT05010434Phase 2
- ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency AblationStatus unknownNCT05009550Not applicable
- Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCCStatus unknownNCT05007587Early Phase 1
- to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver ReserveCompletedNCT05007548Phase 2
- Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular CarcinomaStatus unknownNCT05006326Not applicable
- Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular CarcinomaCompletedNCT05003700Phase 2
- Tislelizumab in the Systematic Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT04996459
- Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic TherapyStatus unknownNCT04994236Phase 2
- TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCCStatus unknownNCT04992143Phase 2
- Study of INCA 0186 in Subjects With Advanced Solid TumorsTerminatedNCT04989387Phase 1
- TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular CarcinomaActive, not recruitingNCT04988945Phase 2
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT04985136Phase 3
- A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionStatus unknownNCT04981665Phase 2
- Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world StudyCompletedNCT04975932
- PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCCStatus unknownNCT04974281Early Phase 1
- Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular CarcinomaStatus unknownNCT04973098Phase 1
- Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation ProceduresCompletedNCT04970212
- DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCCStatus unknownNCT04967482Not applicable
- Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor ThrombosisCompletedNCT04966195Not applicable
- Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver CancerWithdrawnNCT04965714Phase 2
- Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)Active, not recruitingNCT04965259
- Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After SurgeryCompletedNCT04962958Phase 2
- The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04961918Phase 2
- Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular CarcinomaStatus unknownNCT04961138Not applicable
- Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing SurgerySuspendedNCT04955808
- Fusion Imaging Contrast-enhanced Ultrasound LI-RADSStatus unknownNCT04955119Not applicable
- TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)CompletedNCT04954794Phase 2
- Anlotinib for Hepatocellular CarcinomaStatus unknownNCT04954521
- DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumabCompletedNCT04954339Phase 2
- Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor ThrombosisStatus unknownNCT04947826Phase 2
- Adjuvant Therapy With Anlotinib for HCCWithdrawnNCT04947371Phase 2
- Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCCStatus unknownNCT04943679
- SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular CarcinomaCompletedNCT04930315Phase 2
- Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)SuspendedNCT04929015Not applicable
- Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular CarcinomaStatus unknownNCT04926532Phase 1/2
- Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)CompletedNCT04926376Not applicable
- Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCCStatus unknownNCT04920214
- SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular CarcinomaStatus unknownNCT04913480Phase 2
- Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCCStatus unknownNCT04911959Phase 1/2
- The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label StudyStatus unknownNCT04909866Phase 2/3
- Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-SpheresCompletedNCT04903548
- Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal RadiotherapyCompletedNCT04903340
- Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular CarcinomaCompletedNCT04892810
- TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or MetastasisStatus unknownNCT04888546Phase 1/2
- Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPSCompletedNCT04868149Not applicable
- SBRT + Atezolizumab + Bevacizumab in Resectable HCCActive, not recruitingNCT04857684Early Phase 1
- Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTTStatus unknownNCT04850157Phase 2
- A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and OxaliplatinStatus unknownNCT04850040Phase 2
- Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular CarcinomaCompletedNCT04847726Not applicable
- CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency AblationCompletedNCT04844112Not applicable
- Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCCStatus unknownNCT04843943Phase 1/2
- cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven CriteriaCompletedNCT04842565Phase 2
- The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation TherapyCompletedNCT04837742Not applicable
- Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaStatus unknownNCT04834986Phase 2